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INTRODUCTION
Bartonella is the main agent of cat scratch disease
(CSD) and is transmitted to humans after a skin
injury caused by a cat scratch or bite [1]. Gener-
ally benign, it is characterised by regional lymph-
adenopathy; however, it may produce a wide
spectrum of clinical symptoms with life-threaten-
ing complications such as atypical disseminated
forms like bacteraemia and endocarditis and
bacillary angiomatosis, the last commonly associ-
ated with human immunodeﬁciency virus infec-
tion (HIV) [2].
In this study, the characteristics of Bartonella
henselae and B. quintana infections in a Spanish
general hospital have been analysed.
METHODS
The study was performed in Sabadell Hospital, which admits
406 000 inpatients. We carried out a retrospective revision of
the clinical chart of all patients who had a serological test for
Bartonella spp. and showed a positive result between January
1998 and November 2007.
The serum samples were tested by immunoﬂuorescence
assay (IFA) using a commercially available antigen (Bartonella
IFA IgG Substrate slide, Focus Technologies, Herndon, VA,
USA). The kit for detecting IgG antibodies, which uses Vero
cells infected in different spots with B. henselae and B. quintana,
was used according to the manufacturer’s instructions.
In a previous study carried out on a healthy population
sample from the same area (stratiﬁed by age, sex and
demographic area according to the real population) [3],
Bartonella henselae seroprevalence was 8.7% and more than
half of the samples had only 1 ⁄ 64 titres. Therefore titre ‡1 ⁄ 128
was chosen as a cut-off to be considered positive for Bartonella
spp. infection in our patients.
Serological tests against cytomegalovirus (CMV), Epstein-
Barr (EBV) and Toxoplasma were carried out in order to rule
out these diagnoses.
RESULTS
Forty-ﬁve Bartonella spp. seropositive patients
were found. Twenty-ﬁve of them were children
(12 males), with a mean age of 6.9 (1–14 years),
and the other 20 were adults (15 males), with a
mean age of 36.4 (15–62 years).
All the children were immunocompetent
patients. Nine of them had a history of contact
with cats. The typical symptomatology of CSD,
with localised lymph node, was present in 18 with
different localisations: cervical, axillary, inguinal,
submaxillary and supraclavicullary, with cervical
being the most prevalent in 12 cases. Only six of
them presented with fever. Atypical symptoma-
tology was seen in ﬁve of them: fever of unknown
origin, spleen lesions in two, erythema nodosum
or pneumonia. In three cases the lymph node
was extracted and in two cases the lymph
node histological results were obtained showing
a granulomatous necrotising lymphadenitis
(Table 1). All the children recovered well, eight
of them received different antibiotic treatments,
mainly b-lactams or macrolides.
Among the adult patients, ﬁve were infected
with HIV and eleven had had contact with cats.
Sixteen had localised lymph nodes (cervical,
axillary, inguinal, submaxillary), and one HIV
patient had mediastininum and retroperitoneal
nodes. Ten subjects had fever. Four patients
showed an atypical symptomatology (rash, head-
ache, endocarditis) and skin nodular lesions were
observed in one HIV patient. In nine cases, the
histology of the lymph nodes was obtained, with
the diagnosis of chronic granulomatous necrotis-
ing lymphadenitis in six of them. The other
diagnoses were: follicular hyperplasia, reactive
lymphadenitis and lymphoid celularity. We
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obtained a biopsy of one of the lesions from the
patient with skin lesions showing a neovascular
proliferation and the Warthin-Starry silver
stain showed numerous small, dark staining
organisms. The patient was diagnosed with bacil-
lary angiomatosis. The PCR and DNA sequencing
products identiﬁed the organism as a B. quintana.
The patient was treated with doxycycline and
gentamicin, achieving the resolution of the pro-
cess (Table 1). The other ten patients also received
different antibiotic treatment with good evolu-
tion.
Except for ﬁve adults and three children,
serological tests for Toxoplasma, CMV and EBV
could be conducted in all patients. Only one adult
patient showed a positive result to IgM for
Toxoplasma and one child to EBV IgM.
CONCLUSIONS
A Bartonella infection is present in our area.
Excluding other aetiologies such as CMV, EBV
and Toxoplasma, the possibility of a cat scratch
infection, when patients present with fever,
lymph nodes and a history of cat contact,
should be considered. This disease has also been
considered in HIV patients who could present
with more serious infections such as a bacillary
angiomatosis. Atypical clinical forms are not
uncommon. The PCR techniques might be helpful
for the diagnosis of Bartonella infection in immu-
nodepressed patients or when the other tests do
not allow differentiation from other infectious
aetiologies [4,5]. An accurate history, searching
for contact with cats, and a combination of
diagnostic criteria, including serological and
molecular tests and histological ﬁndings, may
allow the diagnosis of these diseases.
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Table 1. Adult and child patients with atypical symptomatology
Case Age (year) Sex Cat Clinical picture
Anti-IgG Bartonella
henselae (1) Histology Treatment
1(2) 37 M Unk Fever, HIV,
skin nodules
1 ⁄ 512 (3) Proliferation
neovascular
Doxycycline
+ gentamicin
2 54 F Yes Fever, rash 1 ⁄ 128, 1 ⁄ 128 – S. resolution
3 31 M No Headache, fever,
meningoencephalitis
1 ⁄ 256, 1 ⁄ 128 – S. resolution
4 59 M Unk Fever, endocarditis 1 ⁄ 256, 1 ⁄ 256 – Ceftriaxone ⁄ 4 w
5 13 F Yes Fever, splenic abscesses 1 ⁄ 128, 1 ⁄ 128 – Ceftriaxone
6 7 M Unk UOF 1 ⁄ 128, 1 ⁄ 128, 1 ⁄ 64 – –
7 9 M Unk Erythema nudosum 1 ⁄ 1024, 1 ⁄ 1024 – –
8 3 M Unk Cervical LN,
fever pneumonia
>1 ⁄ 256, 1 ⁄ 256, 1 ⁄ 128 – Gentamicin
+ clarythromycin
9 4 F No Splenomegaly 1 ⁄ 128 – –
Cat, cat contact; M, male; F, female; Unk, unknown; LN, lymph node; UOF, unknown origin fever; IFI (IgG), more than one result for follow-up; S. resolution, spontaneus
resolution.
(1) Titres from B. quintana were negative or £ two dilutions from B. henselae except case 1. (2) Skin modules PCR positive to B. quintana. (3) Titres from B. henselae, B. quintana
1 ⁄ 512.
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